International Standards for hepatocyte growth factor/scatter factor: initial assessment of candidate materials and their evaluation by multicentre collaborative study.

Hepatocyte growth factor/scatter factor (HGF/SF) is a potent paracrine growth factor with motogenic, mitogenic and morphogenic activities, and a potential therapeutic role in hepatic and renal disease, as well as diagnostic and prognostic applications. It is synthesised as an inactive, single-chain precursor that is cleaved by serine proteases to give a biologically active, heterodimeric form. To develop World Health Organization (WHO) International Standards (IS) for HGF/SF, candidate preparations of the two forms were assessed in a multicentre study in which they were compared with local standards by bioassay and immunoassay. Among laboratories, there was a wide variation in the estimates of potencies of the candidate standards in terms of in-house reference preparations, but between-assay and within-assay variabilities were low within laboratories. In some assay systems, the precursor and heterodimer showed different responses. Since both molecular forms are widely used in current assay systems, this suggested that a reference preparation was required for each form of the HGF/SF molecule. Accordingly, the Expert Committee on Biological Standardization of WHO established the heterodimeric material (96/564) as the first IS for HGF/SF, human, recombinant, with an assigned unitage of 4000 IU/ampoule and, for the purpose of immunoassay calibration, a nominal HGF/SF content of 4 microg/ampoule. The precursor preparation (96/556) was established as the first IS for HGF/SF (precursor) with an assigned unitage of 2000 IU/ampoule and, for the purpose of immunoassay calibration, a nominal HGF/SF (precursor) content of 4 microg/ampoule. The preparations can be obtained upon written request to the National Institute for Biological Standards and Control (NIBSC, PO Box 1193), by e-mail (standards@nibsc.ac.uk) or ordered at http://www.nibsc.ac.uk.

Study of the cardiotoxic potential of pharmaceutical compounds in chick myocardial myocyte reaggregate cultures.

Cardiotoxicity produced by doxorubicin in vivo is considered to be due to a direct effect on the myocardium and this is also a major component with toxicity of isoprenaline and digoxin. In the case of the cardiotoxicity produced at high doses by the antihypertensives hydralazine and pinacidil, an indirect mechanism operating by way of their exaggerated pharmacological effects is believed to be responsible. These compounds were examined for their cardiotoxic potential in vitro using chick myocardial myocyte reaggregate (MMR) cultures; allylamine HCl was used as a positive control. Cultures were incubated for up to 24 hr with each compound; parameters analysed were: spontaneous beating activity (SBA), lactate dehydrogenase (LDH) leakage and microscopic evidence of cytotoxicity. Allylamine, doxorubicin, digoxin and to a lesser extent isoprenaline were highly toxic to MMR cultures, as demonstrated by their effects on SBA, LDH leakage and morphology. Hydralazine showed very mild cytotoxicity at the highest concentrations with no LDH leakage; pinacidil was not cytotoxic but showed a dose-related inhibition of SBA. These results confirm the direct toxic action of doxorubicin and digoxin on myocardial cells and indicate that this is also an important mechanism in vivo for isoprenaline. The lack of any significant toxicity with hydralazine and pinacidil accords with an indirect mechanism based on their pharmacology.

Bile acid assays as an index of cholestasis.

Four bile acid profiles, bilirubin, alkaline phosphatase, alanine aminotransferase, glutamate dehydrogenase, and isocitrate dehydrogenase were measured in rats in which normal bile flow had been disturbed either by administration of alpha-naphthylisothiocyanate or by surgical ligation of the bile duct. The most sensitive index to the early onset of cholestasis was an increase in total cholate. This increase was measurable before morphological changes could clearly be identified.